See study data, get information on access and patient support options, and learn more about this FDA-approved beta-3 adrenergic agonist for overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Northern Ontario Business publication provides Northern Ontario with relevant, current, and insightful editorial content and business news and information.